In vivo real-time dosimetric verification in high dose rate prostate brachytherapy.

@article{Seymour2011InVR,
  title={In vivo real-time dosimetric verification in high dose rate prostate brachytherapy.},
  author={Erin Seymour and Simon Downes and Gerald Blaise Fogarty and Michael A. Izard and Peter E. Metcalfe},
  journal={Medical physics},
  year={2011},
  volume={38 8},
  pages={
          4785-94
        }
}
PURPOSE To evaluate the performance of a diode array in the routine verification of planned dose to points inside the rectum from prostate high dose rate (HDR) brachytherapy using a real-time planning system. METHODS A dosimetric study involving 28 patients was undertaken where measured doses received during treatment were compared to those calculated by the treatment planning system (TPS). After the ultrasound imaging required for treatment planning had been recorded, the ultrasound probe… 
Real-time in vivo dosimetry in high dose rate prostate brachytherapy.
In vivo dose verification method in catheter based high dose rate brachytherapy.
BrachyView, a novel inbody imaging system for HDR prostate brachytherapy: design and Monte Carlo feasibility study.
TLDR
HDR BrachyView is a feasible design for real-time source tracking in HDR prostate brachytherapy and is capable of resolving the source position within a subsecond dwell time.
In–vivo endorectal dosimetry of prostate high dose rate brachytherapy and TomoTherapy ® using MOSkinTM detectors
TLDR
The dual MOSkin system, if employed clinically, could help to detect errors, such as patient shifts or incorrect set–up, in dose delivery for HDR brachytherapy and Helical TomoTherapy R © for the treatment of prostate cancer.
A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking.
TLDR
This work demonstrates a method for directly comparing the treatment plan with the delivered treatment that can be easily implemented in the clinical workspace and provides a noninvasive method of acquiring extensive information for verification in HDR prostate brachytherapy.
Dose assessment in high dose rate brachytherapy with cobalt-60 source for cervical cancer treatment: a phantom study
TLDR
The performance of dose verification test served as an end-to-end quality assurance procedure to verify and validate dose delivery in intracavitary brachytherapy of the cervix and the vaginal walls based on the Manchester system.
BrachyShade : real-time quality assurance for high dose rate brachytherapy
TLDR
HDR BrachyView is an in-body source tracking system designed to monitor the location of a HDR prostate brachytherapy source developed at the Centre of Medical Radiation Physics at the University of Wollongong, based on a tungsten pinhole camera with a silicon pixellated photon detector.
...
1
2
3
4
...

References

SHOWING 1-10 OF 52 REFERENCES
In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations.
Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer
TLDR
TLD in-vivo measurements are easily performed in urethra and rectum during HDR brachytherapy of prostate patients and provide information about the dose delivered to critical structures, which may be of particular interest if higher doses are to be given per fraction such as in HDR monotherapy.
A small tolerance for catheter displacement in high-dose rate prostate brachytherapy is necessary and feasible.
Inverse treatment planning based on MRI for HDR prostate brachytherapy.
An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry.
In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
TLDR
A phantom study for dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer is presented and the method is considered to be suitable for measurements in vivo.
EPR/alanine dosimetry in LDR brachytherapy--a feasibility study.
TLDR
In vivo dosimetry, using electron paramagnetic resonance in l-alanine, performed on 13 patients treated for gynaecological cancers, yielded mixed results, with main sources of differences attributed to uncertainty in the determination of the detector position inside the patient's body and to uncontrolled changes in the detectors position during the treatment.
...
1
2
3
4
5
...